অনুসন্ধান ফলাফলগুলি - Koldej, Rachel
- প্রদর্শন 1 - 17 ফলাফল এর 17
-
1
-
2
-
3
-
4
-
5
-
6
-
7
Dissection of the bone marrow microenvironment in hairy cell leukaemia identifies prognostic tumour and immune related biomarkers অনুযায়ী Koldej, Rachel M., Prabahran, Ashvind, Tan, Chin Wee, Ng, Ashley P., Davis, Melissa J., Ritchie, David S.
প্রকাশিত 2021পাঠ্য -
8
Natural killer receptor ligand expression on acute myeloid leukemia impacts survival and relapse after chemotherapy অনুযায়ী Mastaglio, Sara, Wong, Eric, Perera, Travis, Ripley, Jane, Blombery, Piers, Smyth, Mark J., Koldej, Rachel, Ritchie, David
প্রকাশিত 2018পাঠ্য -
9
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells অনুযায়ী Cooke, Rachel Elizabeth, Quinn, Kylie Margaret, Quach, Hang, Harrison, Simon, Prince, Henry Miles, Koldej, Rachel, Ritchie, David
প্রকাশিত 2020পাঠ্য -
10
Comparison of Insulators and Promoters for Expression of the Wiskott–Aldrich Syndrome Protein Using Lentiviral Vectors অনুযায়ী Koldej, Rachel M., Carney, Gael, Wielgosz, Matthew M., Zhou, Sheng, Zhan, Jun, Sorrentino, Brian P., Nienhuis, Arthur W.
প্রকাশিত 2013পাঠ্য -
11
Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA অনুযায়ী Anson, Donald S, McIntyre, Chantelle, Thomas, Belinda, Koldej, Rachel, Ranieri, Enzo, Roberts, Ainslie, Clements, Peter R, Dunning, Kylie, Byers, Sharon
প্রকাশিত 2007পাঠ্য -
12
Spontaneous onset and transplant models of the Vk*MYC mouse show immunological sequelae comparable to human multiple myeloma অনুযায়ী Cooke, Rachel E., Gherardin, Nicholas A., Harrison, Simon J., Quach, Hang, Godfrey, Dale I., Prince, Miles, Koldej, Rachel, Ritchie, David S.
প্রকাশিত 2016পাঠ্য -
13
Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients অনুযায়ী Davis, Joanne E., Du, Kelei, Ludford-Menting, Mandy J., Prabahran, Ashvind, Wong, Eric, Huntington, Nicholas D., Koldej, Rachel M., Ritchie, David S.
প্রকাশিত 2021পাঠ্য -
14
Immune recovery in patients with mantle cell lymphoma receiving long-term ibrutinib and venetoclax combination therapy অনুযায়ী Davis, Joanne E., Handunnetti, Sasanka M., Ludford-Menting, Mandy, Sharpe, Chia, Blombery, Piers, Anderson, Mary Ann, Roberts, Andrew W., Seymour, John F., Tam, Constantine S., Ritchie, David S., Koldej, Rachel M.
প্রকাশিত 2020পাঠ্য -
15
Recipient BCL2 inhibition and NK cell ablation form part of a reduced intensity conditioning regime that improves allo-bone marrow transplantation outcomes অনুযায়ী Jiao, Yuhao, Davis, Joanne E., Rautela, Jai, Carrington, Emma M., Ludford-Menting, Mandy J., Goh, Wilford, Delconte, Rebecca B., Souza-Fonseca-Guimaraes, Fernando, Koldej, Rachel, Gray, Daniel, Huang, David, Kile, Ben T., Lew, Andrew M., Ritchie, David S., Huntington, Nicholas D.
প্রকাশিত 2018পাঠ্য -
16
Preclinical safety and efficacy of an anti–HIV-1 lentiviral vector containing a short hairpin RNA to CCR5 and the C46 fusion inhibitor অনুযায়ী Wolstein, Orit, Boyd, Maureen, Millington, Michelle, Impey, Helen, Boyer, Joshua, Howe, Annett, Delebecque, Frederic, Cornetta, Kenneth, Rothe, Michael, Baum, Christopher, Nicolson, Tamara, Koldej, Rachel, Zhang, Jane, Keech, Naomi, Camba Colón, Joanna, Breton, Louis, Bartlett, Jeffrey, An, Dong Sung, Chen, Irvin SY, Burke, Bryan, Symonds, Geoff P
প্রকাশিত 2014পাঠ্য -
17
Differential effects of BTK inhibitors ibrutinib and zanubrutinib on NK-cell effector function in patients with mantle cell lymphoma অনুযায়ী Flinsenberg, Thijs W.H., Tromedjo, Charnelle C., Hu, Nan, Liu, Ye, Guo, Yin, Thia, Kevin Y.T., Noori, Tahereh, Song, Xiaomin, Aw Yeang, Han X., Tantalo, Daniela G., Handunnetti, Sasanka, Seymour, John F., Roberts, Andrew W., Ritchie, David, Koldej, Rachel, Neeson, Paul J., Wang, Lai, Trapani, Joseph A., Tam, Constantine S., Voskoboinik, Ilia
প্রকাশিত 2020পাঠ্য